Collaborators
K-Ras signaling and genetics
Andrew Aguirre, Dana-Farber Cancer Institute
Ana Anderson, Brigham and Women's Hospital
Adam Bass, Dana-Farber Cancer Institute
Steven Gygi, Harvard Medical School
William Hahn, Dana-Farber Cancer Institute
Douglas Lauffenburger, Massachusetts Institute of Technology
Carla Mattos, Northeastern University
Matt Steensma, Van Andel Institute
Kimmie Ng, Dana-Farber Cancer Institute
Rona Yaeger, Memorial Sloan Kettering Cancer Center
Inflammatory bowel diseases
CRUK Grand Challenge
Steve Elledge, Brigham and Women’s Hospital
Karen Cichowski, Brigham and Women’s Hospital
Peter Park, Harvard Medical School
Kristian Helin, Memorial Sloan Kettering Cancer Center
Thomas Westbrook, Baylor College of Medicine
Teresa Davoli, New York University
Owen Sansom, Beatson Institutue
Richard Marais, University of Manchester
Hans Clevers, Utrecht University
Synthetic lethal screening
Stephen Elledge, Brigham and Women's Hospital
Steven Gygi, Harvard Medical School
Marcia Haigis, Harvard Medical School
Douglas Lauffenburger, Massachusetts Institute of Technology